ClinVar Miner

Submissions for variant NM_000133.4(F9):c.532T>C (p.Cys178Arg)

dbSNP: rs2148362390
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001982943 SCV002238031 pathogenic Hereditary factor IX deficiency disease; Thrombophilia, X-linked, due to factor 9 defect 2021-02-07 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys178 amino acid residue in F9. Other variant(s) that disrupt this residue have been observed in individuals with F9-related conditions (PMID: 8680410, 8217825), which suggests that this may be a clinically significant amino acid residue. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with hemophilia B (PMID: 7937052, 22639855, 19699296, 22544209, 27529981). This variant is also known as T20374C and p.Cys132Arg. This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with arginine at codon 178 of the F9 protein (p.Cys178Arg). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and arginine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.